Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Saracatinib in platinum-sensitive advanced ovarian cancer
NCT00610714Phase 2Completed
- Sponsor
- AstraZeneca
- Start
- Apr 2008
- Primary completion
- Aug 2009
- Modality
- Small Molecules
- Countries
- 12
01
Overview
A Phase 2 trial of saracatinib in ovarian cancer, sponsored by AstraZeneca. Started Apr 2008; status: completed.
02
Drugs
saracatinib
03
Conditions
ovarian cancer
Beyond the preview
Go deeper on NCT00610714.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00610714.